GSDMD and myocardial infarction: Clinical myocardial samples have demonstrated pronounced co-localisation of PCSK9 with N-terminal gasdermin D (GSDMD-NT) in the peri-infarct zone, implicating PCSK9 in pyroptotic injury during acute myocardial infarction [128].